Table 1.
Demographic and clinical characteristics between thalassemia group and healthy group
| Variables | Patient (n=50) | Control (n=50) | P |
|---|---|---|---|
| Gender (female/male) | 26/24 | 28/22 | 0.688 |
| Age (years) | 23.58±7.94 | 24.77±6.34 | 0.410 |
| BMI (kg/m2) | 18.94±5.72 | 20.78±2.42 | 0.040 |
| HR (bpm) | 71.46±5.98 | 73.79±6.71 | 0.070 |
| SBP (mmHg) | 113.25±10.52 | 114.69±4.62 | 0.379 |
| DBP (mmHg) | 74.72±3.68 | 75.95±4.61 | 0.144 |
| Hemoglobin | 9.21±1.73 | 13.75±2.29 | 0.0001 |
| Ferritin (ng/mL) | 2391.65±409.72 | 110.93±55.97 | 0.0001 |
| CMRT2* | 23.37±5.71 | - | - |
| Age of chelator therapy (years) | 11.52±8.32 | - | - |
| Age of blood transfusion (years) | 13.73±7.29 | - | - |
BMI=Body mass index, HR=Heart rate, SBP=Systolic blood pressure, DBP=Diastolic blood pressure, CMRT2*= Cardiovascular Magnetic Resonance T2*